Maryland Tech Council Announces Nomination of Innovative Cellular Therapeutics as “Emerging Life Sciences Company of the Year” Finalist
March 10, 2020 08:00 ET
|
Innovative Cellular Therapeutics
ROCKVILLE, Md., March 10, 2020 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a clinical stage biotechnology company developing a comprehensive platform of chimeric antigen receptor...
Innovative Cellular Therapeutics Appoints Cell and Gene Therapy Manufacturing Expert Christopher Ballas, Ph.D., as SVP of Manufacturing
January 07, 2020 08:00 ET
|
Innovative Cellular Therapeutics
ROCKVILLE, Md., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a clinical stage biotechnology company developing a comprehensive platform of chimeric antigen receptor...
Innovative Cellular Therapeutics Secures Equity Financing to Advance its Next Generation Liquid and Solid Tumor CAR-T Programs
December 17, 2019 09:04 ET
|
Innovative Cellular Therapeutics
ROCKVILLE, Md., Dec. 17, 2019 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a clinical stage biotechnology company developing a comprehensive platform of chimeric antigen receptor...
Innovative Cellular Therapeutics Strengthens Executive Leadership Team with Appointment of Morten Marott as Chief Financial Officer
December 05, 2019 08:00 ET
|
Innovative Cellular Therapeutics
ROCKVILLE, Md., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a biotechnology company developing a comprehensive platform of chimeric antigen receptor (CAR) T cell...
Innovative Cellular Therapeutics Announces FDA Clearance of IND for its Dominant Negative PD-1 “Armored” Next Generation CAR-T Cell Therapy
December 04, 2019 08:00 ET
|
Innovative Cellular Therapeutics
ROCKVILLE, Md., Dec. 04, 2019 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a biotechnology company developing a comprehensive platform of chimeric antigen receptor (CAR) T cell...